Incannex Healthcare Limited - ADR earnings per share and revenue
On 14 de nov. de 2025, IXHL reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.03 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q2 26, 3 analistas forecast an EPS of -0.03 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
What were Incannex Healthcare Limited - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Incannex Healthcare Limited - ADR reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Incannex Healthcare Limited - ADR's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Incannex Healthcare Limited - ADR expected to report next?
The next earning report is scheduled for 12 de fev. de 2026.
What are the forecasts for Incannex Healthcare Limited - ADR's next earnings report?
Based on 3
analistas, Incannex Healthcare Limited - ADR is expected to report EPS of -$0.03 and revenue of -- for Q2 2026.